Welcome to the homepage of the Institute of Cardiovascular Regeneration. Main focus of our Institute is the research and development of potential therapeutics for the treatment of cardiovascular diseases. The Institute elucidates the basic mechanisms underlying cardiovascular disease and vessel growth with the aim to develop new cellular and pharmacological therapies for improving the treatment of cardiovascular disease. Ongoing research focuses on epigenetic mechanisms that control cardiovascular repair, specifically the function of histone modifying enzymes and non-coding RNAs. Our lab is an international and interdisciplinary team consisting of independent group leaders as well as Postdocs with a medical and basic science background, PhDs and MD students and research associates.
NEWS: Research
Malat1 deficiency prevents neonatal heart regeneration
New paper by Galip Servet Aslan on JCI insight…
Mapping the hypertrophic heart, Nature Cardiovascular Research
New publication in Nature Cardiovascular Research…
Ever wondered how energetic deficiency can drive cellular overgrowth?
New paper by Jaya Krishnan about…
NEWS: Awards & Grants
TRR267 on „Non-coding RNA in the Cardiovascular System“ funded for four more years
The Collaborative Research Center to study non-coding RNA …
Manolis Solomonidis receives August Scheidel Foundation
He received research grant from the August Scheidel Foundation…
Why do men die earlier than women?
As men age, some men lose the Y chromosome in part of their cells…